JAMES DECHAVEZ: Open Payments
NPI 1598277378 · CROWLEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 63 payments from 11 companies in 2025. Trend: 2023 $1,140 · 2024 $858 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $225 |
| Novo Nordisk Inc | 11 | $207 |
| Lilly USA, LLC | 10 | $181 |
| Corcept Therapeutics | 10 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $144 |
| Exact Sciences Corporation | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 4 | $37 |
| ABBVIE INC. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $27 |
Products named: JARDIANCE, Korlym, Wegovy, AIRSUPRA, MOUNJARO, FARXIGA, Ozempic, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
